Global Nicotine Replacement Therapy Market, By Product Type, By Distribution Channel, By Geography

Description

The global nicotine replacement therapy market size is expected to reach US$ 105.34 Bn by 2030, from US$ 53.47 Bn in 2023, exhibiting a CAGR of 10.2% during the forecast period.

Nicotine replacement therapy (NRT) includes a variety of products like patches, gums, lozenges, inhalers, and nasal sprays that help taper nicotine intake for those attempting to quit smoking and other tobacco products. As the health risks of smoking have become more well-known in recent decades due to scientific research, more smokers are motivated to quit. NRT products have proven effective as they release nicotine gradually over time to help relieve cravings and withdrawal symptoms during the initial quitting process without many of the harmful toxins found in cigarette smoke. While willpower alone is still the primary method for smokers to quit, NRT provides an additional evidence-based option that has helped millions of people on their journey toward becoming smoke-free.

Market Dynamics:

The global nicotine replacement therapy market is driven by the rising prevalence of smoking-related diseases and growing awareness about the health risks of tobacco use. However, the market also faces some restraints from the availability of cheaper alternatives to NRT products like e-cigarettes. There is an opportunity for market players to invest in developing more innovative nicotine delivery methods and combination NRT therapies for different lifestyles. Countries with large smoking populations and expanding healthcare systems also present significant market potential. For instance, on May 4, 2023, according to a report published by the Centers for Disease Control and Prevention, in 2021, an estimated 11.5% (28.3 million) of the U.S. adults smoked cigarettes, due to which there was more than US$ 240 billion loss in healthcare spending and nearly US$ 372 billion productivity was lost.

Key Features of the Study:

This report provides an in-depth analysis of the global nicotine replacement therapy market and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global nicotine replacement therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Johnson & Johnson Inc. , Haleon Group of Companies, Imperial Brands plc, Cipla Inc., Pfizer Inc., GLENMARK PHARMACEUTICALS LTD, Fertin Pharma, Philip Morris Products S.A., British American Tobacco plc, Japan Tobacco Inc., Habitrol., Perrigo Company plc, Die betapharm Arzneimittel GmbH, ITC Limited , Sparsha Pharma International Pvt Ltd, and Alkalon A/S
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global nicotine replacement therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nicotine replacement therapy market

Detailed Segmentation:

Global Nicotine Replacement Therapy Market, By Product Type
Inhalers
Gum
Transdermal Patches
Sublingual Tablets
Lozenges
Others
Global Nicotine Replacement Therapy Market, By Distribution Channel
Online
Offline
Global Nicotine Replacement Therapy Market, By Region
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Global Nicotine Replacement Therapy Market, Key Players
Johnson & Johnson Inc.
Haleon Group of Companies
Imperial Brands plc
Cipla Inc.
Pfizer Inc.
GLENMARK PHARMACEUTICALS LTD
Fertin Pharma
Philip Morris Products S.A.
British American Tobacco plc
Japan Tobacco Inc.
Perrigo Company plc
Die betapharm Arzneimittel GmbH
ITC Limited
Sparsha Pharma International Pvt Ltd
Alkalon A/S

Product Code: CMI6521

Table of Content

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
Market Definition and Scope
Executive Summary
Top 3 Market Findings
Top 3 Market Opportunity

3. Key Industry Insights

Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancement
Merger, Acquisition and Collaboration Scenario
Recent Product Approvals/Launches
Company Market Share Analysis

4. Nicotine Replacement Therapy Market, By Product Type, 2018 - 2030 ( US$ Billion)

Introduction
Market Size and Forecast, 2018 - 2030, ( US$ Billion)
Segment Trends
Inhalers, 2018 - 2030( US$ Billion)
Introduction
Market Size and Forecast, 2018 - 2030, ( US$ Billion)
Gum, 2018 - 2030( US$ Billion)
Introduction
Market Size and Forecast, 2018 - 2030, ( US$ Billion)
Transdermal Patches, 2018 - 2030( US$ Billion)
Introduction
Market Size and Forecast, 2018 - 2030, ( US$ Billion)
Sublingual Tablets
Introduction
Market Size and Forecast, 2018 - 2030, ( US$ Billion)
Lozenges
Introduction
Market Size and Forecast, 2018 - 2030, ( US$ Billion)
Others
Introduction
Market Size and Forecast, 2018 - 2030, ( US$ Billion)

5. Nicotine Replacement Therapy Market, By Distribution Channel, 2018 - 2030 ( US$ Billion)

Introduction
Market Size and Forecast, 2018 - 2030, ( US$ Billion)
Online, 2018 - 2030( US$ Billion)
Introduction
Market Size and Forecast, 2018 - 2030, ( US$ Billion)
Offline, 2018 - 2030( US$ Billion)
Introduction
Market Size and Forecast, 2018 - 2030, ( US$ Billion)

6. Nicotine Replacement Therapy Market, By End User, 2018 - 2030 ( US$ Billion)

Introduction
Market Size and Forecast, 2018 - 2030, ( US$ Billion)
Segment Trends
Hospitals, 2018 - 2030( US$ Billion)
Introduction
Market Size and Forecast, 2018 - 2030, ( US$ Billion)
Ambulatory Surgical Centers, 2018 - 2030( US$ Billion)
Introduction
Market Size and Forecast, 2018 - 2030, ( US$ Billion)
Specialty Clinics, 2018 - 2030( US$ Billion)
Introduction
Market Size and Forecast, 2018 - 2030, ( US$ Billion)
Others, 2018 - 2030( US$ Billion)
Introduction
Market Size and Forecast, 2018 - 2030, ( US$ Billion)

7. Nicotine Replacement Therapy Market, By Region, 2018 - 2030 ( US$ Billion)

Introduction
Market Share Analysis, 2018 - 2030, ( US$ Billion)
Segment Trends
By Region
Introduction
Market Size and Forecast, 2018 - 2030, ( US$ Billion)
North America
Introduction
Market Size and Forecast, By Product Type, 2018 - 2030, ( US$ Billion)
Market Size and Forecast, By Distribution Channel, 2018 - 2030, ( US$ Billion)
Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, By Product Type, 2018 - 2030, ( US$ Billion)
Market Size and Forecast, By Distribution Channel, 2018 - 2030, ( US$ Billion)
Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Product Type, 2018 - 2030, ( US$ Billion)
Market Size and Forecast, By Distribution Channel, 2018 - 2030, ( US$ Billion)
Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
China
India
Japan
Australia
South Korea
Asean
Rest Of Asia Pacific
Middle East & Africa
Introduction
Market Size and Forecast, By Product Type, 2018 - 2030, ( US$ Billion)
Market Size and Forecast, By Distribution Channel, 2018 - 2030, ( US$ Billion)
Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
GCC
Israel
Rest Of Middle East
Latin America
Introduction
Market Size and Forecast, By Product Type, 2018 - 2030, ( US$ Billion)
Market Size and Forecast, By Distribution Channel, 2018 - 2030, ( US$ Billion)
Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
Brazil
Mexico
Argentina

8. Company Profiles - Nicotine Replacement Therapy Market

Johnson & Johnson Inc. *
Company Overview
Product/Service Portfolio
Financial Performance
Recent Developments/Updates
Strategic Overview
Haleon Group of Companies
Imperial Brands plc
Cipla Inc.
Pfizer Inc.
GLENMARK PHARMACEUTICALS LTD
Fertin Pharma
Philip Morris Products S.A.
British American Tobacco plc
Japan Tobacco Inc.
Habitrol.
Perrigo Company plc
Die betapharm Arzneimittel GmbH
ITC Limited
Sparsha Pharma International Pvt Ltd
Alkalon A/S

9. References and Research Methodology

References
Research Methodology
About us and Sales Contact